SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-236301
Filing Date
2021-08-04
Accepted
2021-08-04 16:11:26
Documents
8
Effectiveness Date
2021-08-04

Document Format Files

Seq Description Document Type Size
1 S-3ASR d211774ds3asr.htm S-3ASR 403419
2 EX-1.2 d211774dex12.htm EX-1.2 181794
3 EX-4.3 d211774dex43.htm EX-4.3 36796
4 EX-4.4 d211774dex44.htm EX-4.4 261503
5 EX-5.1 d211774dex51.htm EX-5.1 36284
6 EX-23.1 d211774dex231.htm EX-23.1 1706
7 GRAPHIC g211774g51o67.jpg GRAPHIC 2710
8 GRAPHIC g211774g96j22.jpg GRAPHIC 30056
  Complete submission text file 0001193125-21-236301.txt   964292
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: S-3ASR | Act: 33 | File No.: 333-258448 | Film No.: 211144116
SIC: 2834 Pharmaceutical Preparations